Paradoxical embolism after surgery for breast cancer: a case report

por Yu, Zhimin, Deng, Heran, Wang, Jie, Xu, Junyao
Publicado 2020

Impact of Breast Cancer Subtype Defined by Immunohistochemistry Hormone Receptor and HER2 Status on the Incidence of Immediate Postmastectomy Reconstruction

por Wu, Wei, Cheng, Shi, Deng, Heran, Wu, Jiannan, Mao, Kai, Cao, Minghui
Publicado 2016

Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status

por Mao, Kai, Yang, Yaping, Wu, Wei, Liang, Shi, Deng, Heran, Liu, Jieqiong
Publicado 2017

Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A Validation Study

por Chen, Kai, Zhang, Xiaolan, Deng, Heran, Zhu, Liling, Su, Fengxi, Jia, Weijuan, Deng, Xiaogeng
Publicado 2014

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial

por Wu, Wei, Deng, Heran, Rao, Nanyan, You, Na, Yang, Yaping, Cao, Minghui, Liu, Jieqiong
Publicado 2017

Impact of Atypical Hyperplasia at Surgical Margins on breast cancer outcomes in patients treated with neoadjuvant chemotherapy

por Su, An, Zhang, Jing, Liu, Jieqiong, Yang, Yaping, He, Zhou, Bao, Haoshi, Deng, Heran, Wu, Jiannan
Publicado 2023

Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer

por Wu, Jiannan, Li, Shunrong, Jia, Weijuan, Deng, Heran, Chen, Kai, Zhu, Liling, Yu, Fengyan, Su, Fengxi
Publicado 2015

Combined Let-7a and H19 Signature: A Prognostic Index of Progression-Free Survival in Primary Breast Cancer Patients

por Guo, Qiannan, Wen, Runyao, Shao, Bin, Li, Yudong, Jin, Xin, Deng, Heran, Wu, Jiannan, Su, Fengxi, Yu, Fengyan
Publicado 2018

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer

por Yang, Yaping, Wang, Ying, Deng, Heran, Tan, Cui, Li, Qian, He, Zhanghai, Wei, Wei, Zhou, Enxiang, Liu, Qiang, Liu, Jieqiong
Publicado 2019

Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data

por Deng, Heran, Wang, Liying, Wang, Na, Zhang, Kejin, Zhao, Yanxia, Qiu, Pengfei, Qi, Xiaowei, Zhang, Danhua, Xu, Fei, Liu, Jieqiong
Publicado 2023

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial

por Wu, Wei, Chen, Jiewen, Deng, Heran, Jin, Liang, He, Zhanghai, Rao, Nanyan, Nie, Yan, Yao, Yandan, Yang, Yaping, Su, Fengxi, Liu, Jieqiong
Publicado 2021

Multicentre, randomised, open-label, non-inferiority trial comparing the effectiveness and safety of ductal lavage versus oral corticosteroids for idiopathic granulomatous mastitis...

por Hu, Tingting, Li, Shunrong, Huang, Heng, Huang, Hui, Tan, Luyuan, Chen, Yanbo, Deng, Heran, Wu, Jiannan, Zhu, Liling, Zhang, Jian, Su, Fengxi, Chen, Kai
Publicado 2020

HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy

por Jia, Haixia, Jia, Weijuan, Yang, Yaping, Li, Shunrong, Feng, Huiyi, Liu, Jieqiong, Rao, Nanyan, Jin, Liang, Wu, Jiannan, Gu, Ru, Zhu, Liling, Chen, Kai, Deng, Heran, Zeng, Yunjie, Liu, Qiang, Song, Erwei, Su, Fengxi
Publicado 2014